Clinical Trials Logo

Clinical Trial Summary

The proposed project will use fMRI and specific probes of reward and inhibition as biomarkers predicting drug use during and after treatment in 72 subjects addicted to prescription opioids/medications. Subjects will be scanned before, during, and after 12 weeks of active medication. The brain fMRI measures will be correlated with the primary clinical outcome of drug use (by urine drug screen) during the treatment and follow-up phase.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01587196
Study type Interventional
Source University of Pennsylvania
Contact
Status Completed
Phase Phase 2
Start date January 2012
Completion date January 1, 2021